# OnCo record floretyrosine-f18 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/floretyrosine-f18/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "floretyrosine-f18" ;
  schema:name "Floretyrosine F 18"@en ;
  schema:alternateName "floretyrosine F 18"@en, "floretyrosine F18"@en, "floretyrosine"@en, "Pixclara"@en, "Pixclara" ;
  schema:description "Pixclara is a tracer for a PET scan of the brain. After treatment for a glioma, it helps doctors tell whether a change seen on a scan is the tumour growing back or damage caused by the treatment, alongside the other tests."@en ;
  schema:url <https://onco.cc/drugs/floretyrosine-f18/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc78b128-3768-4448-b019-61574db05714>, <https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218592Orig1s000lbl.pdf> ;
  onco:status "approved" ;
  onco:tag "universe-gap", "fda-novel", "diagnostic" ;
  onco:modality "PET radiotracer (radiolabelled amino acid)" ;
  onco:approval "US 2026: PET to differentiate recurrent or progressive glioma from treatment-related change, with other diagnostic evaluations, in adults and children 1 month and older" ;
  onco:related <https://onco.cc/drugs/fluciclovine-f18/> ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/idh-mutant-astrocytoma/>, <https://onco.cc/cancers/oligodendroglioma/>, <https://onco.cc/cancers/paediatric-high-grade-glioma/>, <https://onco.cc/cancers/paediatric-low-grade-glioma/> ;
  onco:technologies <https://onco.cc/technologies/pet/> ;
  onco:companies <https://onco.cc/companies/telix/> ;
  onco:terms <https://onco.cc/terms/radiation-necrosis/> .